In the following video, Motley Fool health-care analyst David Williamson highlights one critical asset for pharmaceutical company Celgene (CELG) -- its management. He gives investors three factors that he sees as essential for the leader of any pharmaceutical company, and tells us how well Celgene's Chairman and CEO Bob Hugin stacks up to those criteria.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.